Journal Article DZNE-2025-00517

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
Correction of dysregulated lipid metabolism normalizes gene expression in oligodendrocytes and prolongs lifespan in female poly-GA C9orf72 mice.

 ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;

2025
Springer Nature [London]

Nature Communications 16(1), 3442 () [10.1038/s41467-025-58634-4]

This record in other databases:    

Please use a persistent id in citations: doi:

Abstract: Clinical and genetic research links altered cholesterol metabolism with ALS development and progression, yet pinpointing specific pathomechanisms remain challenging. We investigated how cholesterol dysmetabolism interacts with protein aggregation, demyelination, and neuronal loss in ALS. Bulk RNAseq transcriptomics showed decreased cholesterol biosynthesis and increased cholesterol export in ALS mouse models (GA-Nes, GA-Camk2a GA-CFP, rNLS8) and patient samples (spinal cord), suggesting an adaptive response to cholesterol overload. Consequently, we assessed the efficacy of the cholesterol-binding drug 2-hydroxypropyl-β-cyclodextrin (CD) in a fast-progressing C9orf72 ALS mouse model with extensive poly-GA expression and myelination deficits. CD treatment normalized cholesteryl ester levels, lowered neurofilament light chain levels, and prolonged lifespan in female but not male GA-Nes mice, without impacting poly-GA aggregates. Single nucleus transcriptomics indicated that CD primarily affected oligodendrocytes, significantly restored myelin gene expression, increased density of myelinated axons, inhibited the disease-associated oligodendrocyte response, and downregulated the lipid-associated genes Plin4 and ApoD. These results suggest that reducing excess free cholesterol in the CNS could be a viable ALS treatment strategy.

Keyword(s): Animals (MeSH) ; Female (MeSH) ; Mice (MeSH) ; Oligodendroglia: metabolism (MeSH) ; Oligodendroglia: drug effects (MeSH) ; Lipid Metabolism: drug effects (MeSH) ; Lipid Metabolism: genetics (MeSH) ; Amyotrophic Lateral Sclerosis: genetics (MeSH) ; Amyotrophic Lateral Sclerosis: metabolism (MeSH) ; Amyotrophic Lateral Sclerosis: drug therapy (MeSH) ; Amyotrophic Lateral Sclerosis: pathology (MeSH) ; C9orf72 Protein: genetics (MeSH) ; C9orf72 Protein: metabolism (MeSH) ; Disease Models, Animal (MeSH) ; Male (MeSH) ; Cholesterol: metabolism (MeSH) ; Humans (MeSH) ; 2-Hydroxypropyl-beta-cyclodextrin: pharmacology (MeSH) ; Mice, Transgenic (MeSH) ; Myelin Sheath: metabolism (MeSH) ; Spinal Cord: metabolism (MeSH) ; Spinal Cord: pathology (MeSH) ; Longevity: drug effects (MeSH) ; Longevity: genetics (MeSH) ; C9orf72 Protein ; Cholesterol ; 2-Hydroxypropyl-beta-cyclodextrin

Classification:

Contributing Institute(s):
  1. Cell Biology of Neurodegeneration (AG Edbauer)
  2. Molecular Neurobiology (AG Simons)
  3. Adaptive Immunity in Neurodegeneration (AG Zhou)
Research Program(s):
  1. 352 - Disease Mechanisms (POF4-352) (POF4-352)
  2. 351 - Brain Function (POF4-351) (POF4-351)

Appears in the scientific report 2025
Database coverage:
Medline ; Creative Commons Attribution CC BY 4.0 ; DOAJ ; OpenAccess ; Article Processing Charges ; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; Current Contents - Agriculture, Biology and Environmental Sciences ; Current Contents - Life Sciences ; Current Contents - Physical, Chemical and Earth Sciences ; DOAJ Seal ; Essential Science Indicators ; Fees ; IF >= 15 ; JCR ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection ; Zoological Record
Click to display QR Code for this record

The record appears in these collections:
Document types > Articles > Journal Article
Institute Collections > M DZNE > M DZNE-AG Edbauer
Institute Collections > M DZNE > M DZNE-AG Simons
Institute Collections > M DZNE > M DZNE-AG Zhou
Full Text Collection
Public records
Publications Database

 Record created 2025-04-14, last modified 2025-05-04